| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2019 | AMRX Amneal Pharmaceuticals, Inc. | Todisco Joseph76 | SVP, Specialty Commercial | Buy | 15,000 | $9.88 | $148,200.00 | +7.9% | |
| May 13, 2019 | NBIX Neurocrine Biosciences Inc | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 1,657 | $75.44 | $125,007.23 | -1.4% | |
| May 13, 2019 | TXMD Therapeuticsmd, Inc. | Thompson Tommy G51 | Director | Buy | 2,400 | $3.34 | $8,016.00 | +0.4% | |
| May 13, 2019 | TXMD Therapeuticsmd, Inc. | Collins Cooper C. | Director | Buy | 30,000 | $3.33 | $99,870.00 | +83.3% | |
| May 13, 2019 | BCRX Biocryst Pharmaceuticals Inc | Staab Thomas R II | Senior Vice President And CFO | Sell | 19,500 | $7.70 | $150,052.50 | -6.8% | |
| May 10, 2019 | IRWD Ironwood Pharmaceuticals Inc | Currie Mark G53 | Director | Sell | 4,055 | $10.53 | $42,699.15 | -0.8% | |
| May 10, 2019 | IRWD Ironwood Pharmaceuticals Inc | Gilbert Halley E | Chief Admin Officer &SVP | Sell | 4,055 | $10.53 | $42,699.15 | -1.7% | |
| May 10, 2019 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 29,453 | $101.65 | $2,993,897.45 | -50.6% | |
| May 10, 2019 | IRWD Ironwood Pharmaceuticals Inc | McCourt Thomas A66 | President | Sell | 4,055 | $10.53 | $42,699.15 | -3.6% | |
| May 10, 2019 | IRWD Ironwood Pharmaceuticals Inc | Consylman Gina | SVP, CFO &Treasurer | Sell | 4,055 | $10.53 | $42,699.15 | -2.3% | |
| May 10, 2019 | EGRX Eagle Pharmaceuticals, Inc. | Braunstein Douglas L | Director | Sell | 159,223 | $56.81 | $9,045,972.85 | -8.5% | |
| May 10, 2019 | BUDZ Weed, Inc. | Breen Nicole M | Secretary And Treasurer | Sell | 15,474 | $0.82 | $12,743.94 | - | |
| May 9, 2019 | RMTI Rockwell Medical, Inc. | Richmond David S. | 10% Owner, See Footnotes 1 And 2 | Buy | 4,643 | $5.65 | $26,211.13 | +0.9% | |
| May 9, 2019 | ALKS Alkermes Plc. | Gaffin David Joseph | SVP, CLO, Alkermes, Inc. | Sell | 5,373 | $26.89 | $144,497.61 | -5.1% | |
| May 8, 2019 | LNTH Lantheus Holdings, Inc. | Markison Brian A64 | Director | Sell | 5,000 | $25.22 | $126,115.50 | -6.5% | |
| May 8, 2019 | CPIX Cumberland Pharmaceuticals Inc | Jacobs Joey A | Director | Buy | 3,846 | $5.87 | $22,577.59 | +0.6% | |
| May 7, 2019 | MRK Merck & Co., Inc. | Clyburn Frank | EVP, Chief Commercial Officer | Sell | 25,000 | $77.73 | $1,943,182.50 | -27.0% | |
| May 6, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Zhou Rong59 | EVP, Production Center | Sell | 9,600 | $22.76 | $218,496.00 | -14.4% | |
| May 6, 2019 | BCRX Biocryst Pharmaceuticals Inc | Staab Thomas R II | Senior Vice President And CFO | Sell | 16,750 | $7.54 | $126,325.00 | -5.9% | |
| May 3, 2019 | MRK Merck & Co., Inc. | Deluca Richard R.45 | EVP&Pres, Merck Animal Heallth | Sell | 35,000 | $80.00 | $2,800,000.00 | -33.0% | |
| May 3, 2019 | LLY Eli Lilly & Co | Shaw Christi | SVP And Pres., Lilly Bio-meds | Sell | 7,577 | $117.14 | $887,570.16 | -93.8% | |
| May 2, 2019 | MRMD Marimed Inc. | Kidrin Thomas | Director | Sell | 100,000 | $3.08 | $307,500.00 | -0.5% | |
| May 1, 2019 | HROW Harrow, Inc. | Kammer Robert J | Director | Sell | 10,000 | $4.57 | $45,700.00 | -1.2% | |
| May 1, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Shandell Jason B. | President And General Counsel | Sell | 10,000 | $21.97 | $219,700.00 | -5.9% | |
| May 1, 2019 | LNTH Lantheus Holdings, Inc. | Markison Brian A64 | Director | Sell | 10,000 | $24.11 | $241,056.00 | -5.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.